NDC 70954-159 – Clorazepate Dipotassium

Clorazepate Dipotassium 3.75 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CIV

Product NDC70954-159

Product details

Brand name
Clorazepate Dipotassium
Generic name
Clorazepate Dipotassium
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA213730
Marketed since
June 16, 2022
Listing expires
December 31, 2026
Pharmacologic class
Benzodiazepine

Active ingredients

Uses, dosage, side effects and warnings for Clorazepate Dipotassium →

Package NDC codes (4)

Package NDCDescriptionSince
70954-159-10100 TABLET in 1 BOTTLE (70954-159-10)Jun 16, 2022
70954-159-20500 TABLET in 1 BOTTLE (70954-159-20)Jul 1, 2022
70954-159-3030 TABLET in 1 BOTTLE (70954-159-30)Aug 21, 2023
70954-159-5030 BLISTER PACK in 1 BOX, UNIT-DOSE (70954-159-50) / 1 TABLET in 1 BLISTER PACK (70954-159-40)Jun 15, 2025

Other Clorazepate Dipotassium products